森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/09 | 1,907 | 1,909 | 1,903 | 1,903 | -14 | -0.7% | 800 |
| 2022/12/08 | 1,909 | 1,917 | 1,902 | 1,917 | +8 | +0.4% | 300 |
| 2022/12/07 | 1,904 | 1,909 | 1,903 | 1,909 | +5 | +0.3% | 1,100 |
| 2022/12/06 | 1,905 | 1,905 | 1,904 | 1,904 | -1 | -0.1% | 400 |
| 2022/12/05 | 1,908 | 1,908 | 1,905 | 1,905 | -3 | -0.2% | 600 |
| 2022/12/02 | 1,911 | 1,911 | 1,907 | 1,908 | -3 | -0.2% | 400 |
| 2022/12/01 | 1,912 | 1,916 | 1,911 | 1,911 | -5 | -0.3% | 500 |
| 2022/11/30 | 1,908 | 1,929 | 1,906 | 1,916 | -8 | -0.4% | 1,800 |
| 2022/11/29 | 1,924 | 1,924 | 1,924 | 1,924 | +20 | +1.1% | 100 |
| 2022/11/28 | 1,919 | 1,919 | 1,904 | 1,904 | -12 | -0.6% | 400 |
| 2022/11/25 | 1,917 | 1,917 | 1,904 | 1,916 | +6 | +0.3% | 1,300 |
| 2022/11/24 | 1,906 | 1,910 | 1,904 | 1,910 | +4 | +0.2% | 1,100 |
| 2022/11/22 | 1,902 | 1,906 | 1,902 | 1,906 | -5 | -0.3% | 500 |
| 2022/11/21 | 1,919 | 1,919 | 1,911 | 1,911 | -1 | -0.1% | 500 |
| 2022/11/18 | 1,910 | 1,912 | 1,910 | 1,912 | -8 | -0.4% | 500 |
| 2022/11/17 | 1,918 | 1,921 | 1,911 | 1,920 | +10 | +0.5% | 500 |
| 2022/11/16 | 1,911 | 1,911 | 1,910 | 1,910 | -6 | -0.3% | 800 |
| 2022/11/15 | 1,910 | 1,916 | 1,910 | 1,916 | -9 | -0.5% | 1,200 |
| 2022/11/14 | 1,921 | 1,925 | 1,913 | 1,925 | +13 | +0.7% | 900 |
| 2022/11/11 | 1,925 | 1,925 | 1,910 | 1,912 | +1 | +0.1% | 1,500 |
| 2022/11/10 | 1,955 | 1,955 | 1,911 | 1,911 | -18 | -0.9% | 3,300 |
| 2022/11/09 | 1,926 | 1,929 | 1,910 | 1,929 | +8 | +0.4% | 4,400 |
| 2022/11/08 | 1,910 | 1,987 | 1,907 | 1,921 | +8 | +0.4% | 7,100 |
| 2022/11/07 | 1,910 | 1,915 | 1,910 | 1,913 | +3 | +0.2% | 1,300 |
| 2022/11/04 | 1,910 | 1,910 | 1,910 | 1,910 | ±0 | ±0% | 1,600 |
| 2022/11/02 | 1,916 | 1,916 | 1,910 | 1,910 | +5 | +0.3% | 600 |
| 2022/11/01 | 1,905 | 1,905 | 1,905 | 1,905 | ±0 | ±0% | 700 |
| 2022/10/31 | 1,905 | 1,905 | 1,905 | 1,905 | ±0 | ±0% | 300 |
| 2022/10/28 | 1,915 | 1,915 | 1,905 | 1,905 | -10 | -0.5% | 200 |
| 2022/10/27 | 1,914 | 1,915 | 1,910 | 1,915 | +10 | +0.5% | 1,100 |
| 2022/10/26 | 1,910 | 1,910 | 1,905 | 1,905 | -7 | -0.4% | 200 |
| 2022/10/25 | 1,909 | 1,912 | 1,908 | 1,912 | +12 | +0.6% | 1,300 |
| 2022/10/24 | 1,900 | 1,900 | 1,900 | 1,900 | ±0 | ±0% | 500 |
| 2022/10/21 | 1,902 | 1,902 | 1,900 | 1,900 | ±0 | ±0% | 1,400 |
| 2022/10/20 | 1,900 | 1,900 | 1,900 | 1,900 | +5 | +0.3% | 200 |
| 2022/10/19 | 1,894 | 1,900 | 1,885 | 1,895 | -1 | -0.1% | 1,800 |
| 2022/10/18 | 1,891 | 1,900 | 1,880 | 1,896 | +15 | +0.8% | 2,000 |
| 2022/10/17 | 1,889 | 1,891 | 1,881 | 1,881 | -1 | -0.1% | 1,100 |
| 2022/10/14 | 1,881 | 1,882 | 1,881 | 1,882 | +1 | +0.1% | 200 |
| 2022/10/13 | 1,884 | 1,884 | 1,881 | 1,881 | -3 | -0.2% | 300 |
| 2022/10/12 | 1,883 | 1,898 | 1,883 | 1,884 | -4 | -0.2% | 600 |
| 2022/10/11 | 1,888 | 1,888 | 1,888 | 1,888 | +6 | +0.3% | 100 |
| 2022/10/07 | 1,883 | 1,883 | 1,882 | 1,882 | -6 | -0.3% | 200 |
| 2022/10/06 | 1,888 | 1,888 | 1,888 | 1,888 | ±0 | ±0% | 200 |
| 2022/10/05 | 1,882 | 1,888 | 1,882 | 1,888 | -9 | -0.5% | 300 |
| 2022/10/04 | 1,897 | 1,897 | 1,897 | 1,897 | +16 | +0.9% | 100 |
| 2022/10/03 | 1,886 | 1,886 | 1,881 | 1,881 | - | - | 400 |
| 2022/09/30 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/09/29 | 1,900 | 1,900 | 1,883 | 1,883 | -17 | -0.9% | 200 |
| 2022/09/28 | 1,888 | 1,900 | 1,888 | 1,900 | +12 | +0.6% | 300 |
651～
700
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 220,000円 | +0.3% | +9.2% | 2.95% | 12.52倍 | 0.74倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| カイオム | 14,200円 | +92.3% | - | 0.00% | - | 5.06倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 坪田ラボ | 37,600円 | +3.2% | -21.7% | 0.00% | 64.27倍 | 6.08倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ＯＴＳ | 2,900円 | +33.3% | - | 0.00% | - | 13.43倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ケイファーマ | 72,500円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
